abnormals

Related by string. abnormal * * abnormal Pap smears . abnormal electrical impulses . abnormal uterine bleeding . abnormal thickening . abnormal prions . abnormal prion protein . abnormal hemoglobin . abnormal gait . abnormal clumps . abnormal heartbeat . abnormal heartbeats . abnormal mammogram . abnormal mammograms . abnormal lipid . abnormal Pap test . abnormal curvature *

Related by context. All words. (Click for frequent words.) 60 unusuals 57 Normalised earnings 57 A#.#m [005] 56 underlying NPAT 56 goodwill amortization 55 npat 55 A#.#m [003] 55 US#.#m [002] 55 tax npat 55 Normalised 55 amortization Ebita 54 ebit 54 exceptionals 54 NPAT 53 #.#ca share [003] 52 mln nzd 52 FY# NPAT 52 NZ#.#m [002] 52 heps 51 fullyear 51 Amortisation EBITDA 51 excluding nonrecurring 50 AIFRS 50 EBITDAF 50 R# ,2 [002] 50 R# 7m [002] 50 #cps 50 #.#ca share [002] 50 R# 4m [002] 50 amortization EBITA 50 Pro forma EPS 49 EBITA 49 Negatively impacting 49 Underlying pretax 49 profi t 49 A#.#b [002] 49 £ #.#ma [005] 49 EBITDA1 49 Unfavourable Changes 49 SFr#.# billion [002] 49 #.#-#.# bln eur [003] 49 EUR -#.# -#.# [001] 48 #.# mln aud 48 EDITDA 48 EBITDAO 48 proft 48 EBIT 48 excluding goodwill impairment 48 R# 2m 48 NZ#m [001] 48 R# 8m [001] 48 Sfr#.#bn [002] 48 amortization ebitda 48 #-# mln sfr 48 NZ#.# [004] 48 pretax profit 48 extraordinaries 48 STG#.# [006] 48 MTM adj 48 SEK -#.# [002] 48 Exceptional Items 48 RCOP 48 R2 8bn 48 SKr#.#bn [003] 48 Pro forma Adjusted EBITDA 48 ZAR#.# billion [002] 47 partly franked 47 ebitda 47 R# ,# [002] 47 fully franked dividends 47 SEK -#.# [001] 47 excluding exceptionals 47 pretax 47 profit 47 mboepd 47 pretax profits 47 pretax goodwill impairment 47 A#.#bn 47 #.# bln aud [001] 47 writebacks 47 R# 6m [002] 46 CHF#.# billion [002] 46 JPY#.# billion [001] 46 distributable earnings 46 #.#per diluted 46 1H FY# [002] 46 R# ,9 [001] 46 #.#m £ #.#m [002] 46 EUR1 #.#m 46 Headline PBIT 46 earnings 46 operatingincome 46 Individual Annuities segment 46 unfranked dividend 46 A#.#m [004] 46 noncash goodwill impairment 46 sees FY pretax 46 ¥ #.#bn [001] 46 R# 4m [001] 46 ebita 46 SEK -#.# -#.# [003] 46 operating income1 46 #.#ma [005] 46 SEK #.#M #.# 46 Futuris 46 #.#-#.# mln [004] 46 MYR#.# [005] 46 EBIT amounted 46 SFr#.#bn [002] 46 per dilutedshare 45 Ebita 45 Pretax 45 Q2 F# 45 diluted HEPS 45 reinstatement premiums 45 ZAR#m 45 £ #.#m £ #.#m 45 SFr#.#bn [001] 45 PLN #.#mn [001] 45 depreciation amortization 45 A#m [002] 45 DAC unlock 45 #.#cps [002] 45 E#.#m [002] 45 1H NPAT 45 Pretax profits 45 #.#ma [002] 45 £ #.#m H# 45 Adjusted EBITDA excludes 45 #.#-#.# mln usd 45 Lillie Rubin chain 45 JPY#.#bn [001] 45 normalized EBITDA 45 £ #.#ma [004] 45 #.#/diluted share 45 Normalised headline 45 SEK -#.# -#.# [001] 45 #.#-#.# bln dkr [002] 45 #.#ca [004] 45 CHF#.#bn [002] 45 proforma EPS 45 revenues excluding nonrecurring 45 normalized EPS 45 R# ,6 [001] 45 #.#/ADR increasing 45 reinsurance recoveries 45 Excluding goodwill impairment 45 R# 3m [001] 45 AUD#.# [003] 45 R# ,1 billion 45 Oilseeds Processing operating 45 Noni B 45 cents ashare 45 Sees FY 45 SKr#.#bn [002] 45 adjusted HEPS 45 #.#p #.#p [007] 44 Headline earnings 44 SwFr#.# billion 44 #.#bn rub [004] 44 1H pretax 44 #c/share [001] 44 excluding reimbursables 44 EBITD 44 noncash accounting 44 Consolidated OIBDA 44 REBIT 44 SEK1 #m 44 Cobalt Gordian 44 George Raftopulos 44 property revaluations 44 noncash impairment 44 SGARA 44 Amcil 44 Projected FFO per 44 R# 9m [002] 44 #.#cps [001] 44 R#m R#m [002] 44 MA PFFS 44 MSEK -# [002] 44 AUD#.# [004] 44 MSEK -#.# 44 goodwill writedown 44 non recurring 44 NON RECURRING ITEMS 44 = Income [004] 44 nonoperating items 44 OSIs 44 A#m [001] 44 depreciation amortization impairment 44 assets RoA 44 earnings pershare 44 € #.#ma [002] 44 #.#-# mln [001] 44 SFr#.# billion [003] 44 fiscal# 44 NZ#.# [002] 44 netincome 44 #.#-#.# mln eur [002] 44 intangible impairment 44 #.# perdiluted 44 HK#.# [002] 44 TEB adjustment 44 pretax noncash 44 adj EPS 44 ZAR#.# [003] 44 Qualcomm Strategic Initiatives 44 EUR -#.# [001] 44 € #,# bn [002] 44 ended September# 44 amortization EBIDTA 44 US#.#bn [001] 44 R# 8m [002] 44 #.#-#.# bln eur [005] 44 adjusted EBITDAS 44 normalized EBIT 44 amortization Ebitda 44 RM#.#mil [006] 44 #,# c [002] 44 NZ#.#m [001] 44 ııı# [001] 44 SFr#.#bn [003] 44 Programmed Maintenance 43 H1 FY# [001] 43 SEK#.#m [001] 43 Q# revs 43 DKK #.#bn [001] 43 STG#.# [001] 43 GBP #.#m [002] 43 excluding BIBP 43 A#.#b [001] 43 #.#ma [004] 43 INR#.# [001] 43 DKK#.# billion [002] 43 excluding depreciation amortization 43 prioryear 43 pre exceptionals 43 Scantron segment decreased 43 E#.#m [005] 43 '#m [001] 43 Y#.#bn [003] 43 Y#.#bn [002] 43 Futuris Corporation 43 Stg#.# billion [003] 43 divestments Novartis 43 #.#bn rub [001] 43 JPY#.#bn [002] 43 proforma revenues 43 NZX WHS 43 taxation depreciation 43 KWD#.# [004] 43 US#.#b [001] 43 SEK#.#bn [004] 43 SKr#.#bn [001] 43 Stg#.# [002] 43 A#.# #.#c 43 halfyear 43 - AdjusETON 43 Housebuilder Bovis 43 HK#.# [004] 43 noncash pretax charge 43 R3 #bn [001] 43 #.#-#.# excluding 43 £ #.#m [004] 43 US#.#m [001] 43 ¤ #.#m 43 S#.# [001] 43 LIFO adjustment 43 Favourable Changes total 43 diluted EPS 43 impairment charges 43 Including discontinued operations 43 Ebidta 43 miner Iluka Resources 43 R# 3m [002] 43 - SegmentPrincess Dina Mired 43 FY pretax 43 j Includes 43 Chemnet 43 CHF#.#bn [001] 43 noncash goodwill 43 writedowns 43 inforce premiums 43 invisibles surplus 43 UBSe 43 totaled EUR#.# 43 Won#.#bn 43 Non GAAP EPS 43 Scantron segment increased 43 excluding nonrecurring items 43 Background Screening segment 43 doubtful debts 43 R3 5bn 43 Underlying EBIT 42 uncollectible accounts receivable 42 NZ9 42 US#.#bn [004] 42 £ #.#bn [005] 42 Adjusted Ebitda 42 Noninterest expense decreased 42 Excluding discontinued operations 42 lfl 42 EUR -#.# [003] 42 R# ,6 [002] 42 Gluskie 42 R# 9m [001] 42 IC COMMENT 42 fully franked dividend 42 SwFr# 42 items affecting comparability 42 #.#mln rub [005] 42 US3c 42 Favourable Changes 42 loan chargeoffs 42 ANZO 42 Stg#.# billion [002] 42 EBITDAC 42 nonrecurring items 42 Fully diluted EPS 42 GBP #.#m [001] 42 pretax noncash charges 42 #.#ca share [001] 42 Ebita margin 42 SELECTED HOSPITAL STATISTICS 42 GBP#M [002] 42 income1 42 BJ Wholesale 3Q 42 R4 4bn 42 #.#pa share [003] 42 JPY#.# trillion [002] 42 Sees FY# 42 = Income [003] 42 Timberland disposals net 42 Excluding nonrecurring items 42 pro forma adjusted EBITDA 42 R#.#m [007] 42 JPY#.# billion [003] 42 eased 3c 42 client reimbursables 42 Supervalu 3Q 42 capital employed ROACE 42 R# 7m [001] 42 Non GAAP adjusted EBITDA 42 annualise 42 Recurrent expenditure 42 #.#-#.# bln eur [002] 42 franked dividend 42 #.#ca [005] 42 Non GAAP Adjusted EBITDA 42 Oil refiner Caltex 42 UKpound 42 LBITDA 42 YTD Q3 42 excludes unrealized gains 42 opg profit 42 #.#billion £ #.#billion 42 IBNR reserves 42 normalized FFO 42 Consolidated EBITDAR 42 R# ,8 [002] 42 LIFO inventory valuation 42 FY pretax profit 42 HEPS 42 ninemonths 42 LIFO expense 42 EBIDTA 42 Q2 FY'# 42 EPS 42 DKK#m [002] 42 EBITDAA 42 Ralphs writedown 42 FHLB borrowings decreased 42 Djerriwarrh Investments 42 R# 5m [002] 42 Euro#.# [003] 42 GBP#.#m [002] 42 US#.#billion [002] 42 Continuing Ops 42 bln nzd 42 MNOK #.# 42 NZ Superannuation Fund 42 TEUR -# 42 Mr Wozniczka 42 Tax NPAT 42 intersegment revenues 42 GBP#.# billion [001] 42 £ #.#bn [002] 42 stg# [001] 42 #.#-#.# bln [007] 42 Pounds #.#m [001] 42 Multex consensus 42 A#.# [002] 42 SEK -# 42 R4 1bn 42 average assets ROAA 42 NZ#c 42 #.#mln rub [006] 42 ¥ #.#bn [003] 42 GBP#.#M [003] 42 profit beia 42 EBTIDA 42 #.#p #.#p [008] 41 #-#.# mln eur 41 Tabcorp Holdings Ltd 41 ¥ #.#bn [002] 41 mln eur vs 41 amortisations 41 9M FY# [001] 41 Items impacting comparability 41 Ebit 41 PBDIT 41 JasmineSola brand 41 Sfr#.#bn [001] 41 Earnings 41 NZ# [002] 41 R# ,4 [002] 41 affecting comparability 41 PLN#.# [004] 41 DNOI 41 revenues teb 41 #.#ca [002] 41 #.#ca [003] 41 Sees FY# adj EPS 41 #,# c [003] 41 taxes EBDDT 41 Noninterest Expense Noninterest expense 41 kronor ¤ 41 asset disposals 41 firmed 2c 41 Rs.#.# crores [006] 41 Sees FY# revs 41 Gross Profit Gross 41 JPY#.#bn [003] 41 GBP#.#M [002] 41 Rs.#.# crores [008] 41 underlying pretax 41 R6 7bn 41 depreciation 41 Fy# 41 Allco Equity 41 writeback 41 bln sgd 41 SHAREHOLDERS FUNDS 41 Andrew Mohl 41 Consolidated adjusted EBITDA 41 Rs#.#cr [001] 41 Q4 FY'# 41 R3 9bn 41 Profit Surges Quick Facts 41 - Adjusted [028] 41 Australand Property Group 41 pcp 41 ungeared 41 millionand 41 R4 2bn 41 CHF4 41 adjusted distributable cash 41 #Ac 41 Consolidated Adjusted OIBDA 41 SFr#m [001] 41 cashflows 41 R3 3bn 41 Lensworth property 41 GAAP EPS 41 Q1 FY'# 41 goodwill impairments 41 mainline CASM excluding 41 #-#.# mln [002] 41 Dhs1 #m 41 pro forma 41 CHF#.# billion [001] 41 Harvey Norman HVN 41 ¥ #B [001] 41 Invested assets 41 SKr#m 41 SEK -#.# [003] 41 lfl sales 41 ASUR regulated 41 R# ,3 [002] 41 A#bn 41 CYP #k 41 Rs#.#mn [002] 41 EUR#.#b 41 Brett Le Mesurier 41 c Consists 41 Octane Additives 41 Mirrabooka Investments 41 kronor euro#.# [004] 41 R# 9bn 41 intangibles amortization 41 WHSP 41 Q1 #F 41 amortization EBITDA 41 Normalized EPS 41 Interest Expense Interest expense 41 aftertax gain 41 Lensworth 41 DKK #.#bn [002] 41 #.Net 41 write downs 41 Tabcorp Holdings 41 reimbursables 41 CHF#m [002] 41 Significant Items 41 - Adjusted [013] 41 NOK#.#m 41 NKr 41 capital employed RoCE 41 #.#ca [001] 41 Djerriwarrh 41 US#.#bn [003] 41 ¥ #.#bn [004] 41 US#.# [005] 41 #.#-#.# bln usd [004] 41 Noninterest expense totaled 41 Q4 adj EPS 41 EPADS estimates 41 Sfr#bn 41 ııı#.# billion [001] 41 fy# 41 intangible impairments 41 Unallocated Corporate 41 b Excludes 41 infrequently occurring 41 aftertax 41 COS Restructuring 41 Recurring EBITDA 41 RM#.#mil [007] 41 Tax PBT 41 nonoperating income 41 kg ms 41 Fruit distributor Fyffes 41 Dhs2 #m 41 #.# mil rub [003] 41 ATCF 41 reinvested distributions 41 AED#.#m 41 PVNBP basis 41 Adjusted EBITDAX 41 Rs#mn [001] 41 NOK#.# [005] 41 NZ2 41 Rs#.#b [001] 40 CASM excluding fuel 40 ID nSYU# 40 Y#.# billion [001] 40 € #.#ma [003] 40 NZ#.# [005] 40 WWS Divestiture 40 #.#-# mln eur [002] 40 US1 ¢ 40 Capital Employed 40 Byproduct revenues 40 EBTA 40 Adjusted Homebuilding EBITDA 40 Corporate Overhead 40 EPRA NAV 40 profit RCOP 40 up#.# [002] 40 budget offshoot Jetstar 40 OTTI write downs 40 Pro Forma EBITDA 40 Earning Per Share 40 R5 6bn 40 millioncompared 40 #c fully franked 40 SFr#.# [003] 40 Rs.#.#cr 40 LFQ gross 40 cashflow 40 REVENUE Revenue 40 R# ,5 [002] 40 bps YoY 40 Guy Hallwright 40 GBP #.#m [003] 40 net 40 FAS CAS pension 40 #.#p [011] 40 Items excluded 40 #.#ma [001] 40 writedown 40 Insurer Catlin 40 PTOI 40 pretax writedowns 40 NZ#m [002] 40 EBDITA 40 Rs#.#mn [001] 40 intersegment eliminations 40 EPADS 40 - Adjusted [010] 40 US#million [001] 40 Deikmann 40 JPY#.# billion [002] 40 OREO valuation 40 profits 40 GBP#.# [005] 40 TWACS NG software 40 GBP #.#bln [001] 40 Urbus Properties 40 SEK#.#bn [002] 40 £ #.#bn [007] 40 equity RoE 40 Equity Investees 40 Profit Rises Quick Facts 40 US#c [002] 40 Paperboard Packaging segment 40 purposes Torchmark defers 40 Profit Rises Update 40 unrealized derivative gain 40 GBP#.#bn [003] 40 FY# revs 40 currency remeasurement 40 R6 3bn 40 R3 4bn 40 reiterates FY 40 Postie Plus 40 IDR#.# trillion [004] 40 Downstream CCS 40 Harland Acquisition 40 Footnote Table 40 non gaap 40 LKR# [001] 40 ROFE 40 eased 2c 40 Sees FY# EPS 40 #.#mln rub [001] 40 ZAR#.# billion [001] 40 seasonally quieter 40 R#.# bn 40 Adjusted Diluted EPS 40 Rival Rio Tinto 40 R7 1bn 40 Adjusted EBITA 40 nonstandard measure 40 intangible asset impairments 40 R1 6bn 40 ROACE 40 Limited Brands 1Q 40 R1 #bn [001] 40 SKr 40 b Reflects 40 unrealized derivative gains 40 Rs.#.# Cr [003] 40 Operating Expenses Operating 40 FY# [001] 40 noninterest expense decreased 40 proforma 40 Items affecting comparability 40 Stg# [001] 40 Australand 40 #.# bln sfr [002] 40 SEK#.#bn [001] 40 #,# #,# #,# [010] 40 Adjusted EBITDA1 40 early extinguishments 40 upholstery fabrics segment 40 NZSF 40 NZ3 40 items impacting comparability 40 YTD# 40 H1 pretax 40 Diluted HEPS 40 temporary impairments OTTI 40 Surface Specialties acquisition 40 adjusted1 net 40 Other Specified Items 40 GBPm GBPm 40 NOK#.# billion [002] 40 R# 4bn 40 US8 ¢ 40 posts 3rd qtr 40 - Loss [010] 40 noninterest expense partially offset 40 JPY#.# billion [004] 40 Blue Oar 40 NZD# [001] 40 n#.# [002] 40 ZAR#.# [006] 40 Pretax profit 40 Aristocrat ALL 40 = Operating [002] 40 SFr#.# billion [004] 40 GBP#.#m [004] 40 adjusted EPS 40 PLN#.# billion [002] 40 CFS Retail 40 Nonoperating 40 noncash writedown 40 SEK#.# [006] 40 R# 3bn 40 #.#-#.# mln stg [002] 40 #.#mln rub [003] 40 R# 6m [001] 39 Y#bn [002] 39 DKK #m 39 Q1 revs 39 AAPT PowerTel 39 profts 39 ııı#.# billion [002] 39 qtrly 39 nonrecurring 39 investees partially offset 39 OneSteel Ltd 39 Core FFO 39 - - EarningsGordan Strachan 39 #.#-#.# mln [001] 39 R3 2bn 39 ½ p valuing 39 goodwill impairment charge 39 Sfr 39 .#/share 39 Underwriting Income Loss 39 #.#bn rubles 39 R# ,7 [002] 39 CAD#m [002] 39 - IncomeMarkit Economics showed 39 #.#-#.# bln dkr [001] 39 - Adjusted [030] 39 Oxy ER 39 hefty goodwill impairment 39 intercompany eliminations 39 GBP#.# [001] 39 Timeshare segment 39 EBITDA 39 DKK#.#bn [001] 39 CHF#.#m [001] 39 interim dividend 39 Incitec Pivot 39 excluding divestments 39 NOPAT 39 fuel CASM 39 Unallocated corporate 39 HK#.# [003] 39 BioGlue revenues 39 = Adjusted [002] 39 EBITA margin 39 AUD#m 39 INR#.#bn [004] 39 - Adjusted [026] 39 H1 pretax falls 39 Sees Q2 39 intangibles impairment 39 Partnered Brands segment 39 From Operations AFFO 39 Rs #.#cr [006] 39 noncash impairments 39 Sept qtr 39 R2 7bn 39 EU#.# [004] 39 R4 6bn 39 eased 1c 39 £ #.#m [005] 39 deductible goodwill impairment 39 #.#-#.# bln usd [002] 39 income teb 39 US#.#c [001] 39 9M FY# [002] 39 Consolidated EBITDA Margin 39 NOK#.# [006] 39 Diluted EPS 39 LPT Agreement 39 Sees Q# 39 Y#.#bn [001] 39 EUR# mn [002] 39 - Loss [013] 39 Daily ShareChat 39 b Represents 39 Servers ESS reported 39 NON CASH EXPENSES 39 ATOI 39 DAC unlocking 39 fully imputed 39 CHF#.# [001] 39 MSR valuation 39 E#.#m [003] 39 #compared 39 Adjusted EBIT 39 totaled E#.# 39 Incitec 39 £ #.#ma [003] 39 EBIAT 39 Truckload segment 39 R1 9bn 39 #.#cr [003] 39 CAD#.# [005] 39 yearearlier 39 MEUR -#.# 39 divident 39 USD#.#m USD#.# per [002] 39 f Represents 39 Dh#.#m [004] 39 CHF #.#M 39 R2 1bn 39 USOGP 39 unrealized derivative 39 Profit 39 MNOK #,# 39 mainline CASM 39 - Loss [032] 39 franked dividends 39 Insurer QBE 39 Pro Forma EPS 39 H1 FY 39 R# ,1 [002] 39 Q4 F# 39 vs #.#m bt 39 R4 5bn 39 4Q FY# 39 - - Income [031] 39 RO#.#m 39 Visa indemnification 39 GUD Holdings 39 #-# mln dkr 39 - - Income [023] 39 amortization OIBDA 39 distributable 39 R1 #,# [002] 39 eased 5c 39 amortization OIBA 39 H1 FY# [002] 39 ₤ #m [001] 39 adjusted Ebitda 39 Eur#.# [003] 39 RM#.#mil [002] 39 Forsyth Barr 39 EUR#.#bn [003] 39 CHF#.#bn [003] 39 pension curtailment 39 Operational EBITDA 39 R1 ,# billion [001] 39 depreciation amortization depletion 39 Mr Deverall 39 Positively impacting 39 Stg#.# billion [001] 39 mln aud 39 EBITDAS EBITDA 39 GBP#.#M [001] 39 EBIT margin 39 - - Earnunderwent resection 39 #.#/ADR 39 pershare 39 mln Sfr 39 R5 ,# 39 Goldman Sachs JBWere 39 MSR impairment 39 SIT #.#bn [003] 39 ncome 39 boardwear division 39 A#.# [007] 39 LIFO adjustments 39 loss NOL carryforward 39 Consolidated Entity 39 = Earnings [019] 39 Pounds #.#m [002] 39 reinsurance reinstatement 39 #c #c [002] 39 EBIDA 39 Valad Property 39 Summarized consolidated 39 Y#.# billion [002] 39 aA 39 AUD#.# [005] 39 Rs #.#mn 39 Dexus Property Group 39 NZ# [001] 39 unrealized hedging 39 PLN #.#m [002] 39 Wireline adjusted EBITDA 39 #,# c [001] 39 #.#mln rub [007] 39 NOK#.# [001] 39 € #.#m [002] 39 Ps.3 39 Baycorp 39 SFr#.# [007] 39 R1 8bn 39 SEK#.#m [002] 39 date Wholesale Leathercraft 39 Turnover amounted 39 - InFree Documentation License 39 A#.#m [002] 39 nonGAAP 39 MSEK -# [001] 39 R1 2bn 39 SEK#.# billion [001] 39 Clive Anthonys 39 AU#.# [002] 39 NZ#.#m [004] 39 INR#.# [002] 39 £ #.#m [006] 39 foreign currency remeasurement 39 Rs #.#cr [005] 39 IDR#.# trillion [002] 39 c Relates 39 EEV basis 39 #.#m bt #.# 39 Rmb#.# [002] 39 ¥ #.#B [001] 38 adjusted EBIT 38 Stg# [002] 38 DKK#.#bn [002] 38 nonrecurring expenses 38 #,# -BOB SANSEVERE 38 writeoffs 38 PRE TAX OPERATING EARNINGS 38 Kimberly Clark 4Q 38 CHF#.#B 38 expenses totaled Ps 38 Tianyin achieved 38 NZ sharemarket rises 38 IDR#.# billion [001] 38 R4 #bn [002] 38 Q3 FY'# 38 AOCF 38 per share1 38 RUB#.#bn [002] 38 NZX# index 38 FY opg 38 nonroutine income 38 adjusted EBITDA 38 - Adjusted [009] 38 CAD#.# [001] 38 FY'# [001] 38 pro forma EBITDA 38 SAR#.# [003] 38 KD#.# [005] 38 Operating Expense Ratio 38 JPY#bn [002] 38 NZ7 38 Rs #.# lacs [002] 38 profitsharing 38 Q#-Q#/# [002] 38 TEUR -#,# 38 noninterest expense totaled 38 LIFO inventory adjustments 38 - Adjusted [020] 38 nonoperating expense 38 undistributed profits 38 loan originations totaled 38 noncash pretax impairment 38 R#.# [001] 38 FY Pretax Pft 38 AUD1 38 LIFO provision 38 OTTI charges 38 Fonterra payout 38 EnPro consolidated 38 Tutt Bryant 38 Segment EBIT 38 fully franked interim 38 Phil Chronican 38 YonY 38 stocks Sharemarket 38 Rs#cr [001] 38 R# ,3 [001] 38 Wireline segment 38 Unfunded pension liability 38 JPY8 38 loanbook 38 Rs #.#cr [001] 38 Catastrophe losses 38 FY#/# [002] 38 Rs #,#.# crore 38 NZX AIR 38 exclude noncash 38 - Loss [017] 38 EPS accretive 38 Amortization OIBDA 38 #.# mln sfr 38 Prepaid ARPU 38 proforma basis 38 SEK#.#bn [003] 38 1/share 38 Mr Buonaccorsi 38 Phosphates segment 38 Previous Corresponding Period 38 reinsurance commutations 38 Purse TBA 38 EUR#.#M [003] 38 adopting SFAS #R 38 A#.#m [001] 38 GSJBW 38 MSR hedging 38 #.# bln dkr [002] 38 R3 1bn 38 R# 8bn 38 #.#m bt [001] 38 RUB #.#bn [001] 38 Abano Healthcare 38 Aspect Huntley 38 ₤ #.#bn 38 R# ,4 [001] 38 ANZ Banking 38 H1 pretax loss 38 KRW#.# trillion [002] 38 Wealth Management AWM 38 eased 4c 38 e#.#m [002] 38 disposals

Back to home page